Haemonetics (HAE) Tops Q1 EPS by 1c, provides guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $73.00 -1.58%
EPS Growth %: -0.9%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $336.17 million versus the consensus estimate of $335.05 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.45-$4.75, versus the consensus of $4.60.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX signs compute deal with Reflection - CNBC
- Lionsgate Studios (LION) June 16, 17 and 18 calls active
- Western Digital (WDC) call put ratio 1.2 calls to 1 put a focus on July 810 calls into Micron (MU) quarter results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
